Amedeo's Top 20

Amedeo Smart

Independent Medical Education

05 February 2024

Multidisciplinary Journal Club

  1. Hashash JG, Elkins J, Lewis JD, Binion DG, et al.
    AGA Clinical Practice Update on Diet and Nutritional Therapies in Patients With Inflammatory Bowel Disease: Expert Review.
    Gastroenterology 2024.

  1. Morris HR, Spillantini MG, Sue CM, Williams-Gray CH, et al.
    The pathogenesis of Parkinson's disease.
    Lancet 2024;403:293-304.

  2. Weber JS, Carlino MS, Khattak A, Meniawy T, et al.
    Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study.
    Lancet 2024.

  3. Onnis C, Virmani R, Kawai K, Nardi V, et al.
    Coronary Artery Calcification: Current Concepts and Clinical Implications.
    Circulation 2024;149:251-266.

  4. Ben-Shlomo Y, Darweesh S, Llibre-Guerra J, Marras C, et al.
    The epidemiology of Parkinson's disease.
    Lancet 2024;403:283-292.

  1. Di Matteo A, Bathon JM, Emery P.
    Rheumatoid arthritis.
    Lancet 2023;402:2019-2033.

  2. Georgianos PI, Agarwal R.
    Resistant Hypertension in Dialysis: Epidemiology, Diagnosis, and Management.
    J Am Soc Nephrol 2024.

  3. Trolle Lagerros Y, Grotta A, Freyland S, Grannas D, et al.
    Risk of Death in Patients With Coronary Artery Disease Taking Nitrates and Phosphodiesterase-5 Inhibitors.
    J Am Coll Cardiol 2024;83:417-426.

  4. Aggarwal R, Heller G, Hillman DW, Xiao H, et al.
    PRESTO: A Phase III, Open-Label Study of Intensification of Androgen Blockade in Patients With High-Risk Biochemically Relapsed Castration-Sensitive Prostate Cancer (AFT-19).
    J Clin Oncol 2024.

  5. Joosten LPT, van Doorn S, van de Ven PM, Kohlen BTG, et al.
    Safety of Switching from a Vitamin K Antagonist to a Non-Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients with Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled Trial.
    Circulation 2023.

  1. Sie A, Ouattara M, Bountogo M, Boudo V, et al.
    Azithromycin during Routine Well-Infant Visits to Prevent Death.
    N Engl J Med 2024;390:221-229.

  2. De Angelis S, Medda E, Rotondi D, Masocco M, et al.
    Fifteen Years of Iodine Prophylaxis in Italy: Results of a Nationwide Surveillance (Period 2015-2019).
    J Clin Endocrinol Metab 2024;109:e495-e507.

  3. Tangri N, Mathur VS, Bushinsky DA, Klaerner G, et al.
    VALOR-CKD: A Multicenter, Randomized, Double-Blind Placebo-Controlled Trial Evaluating Veverimer in Slowing Progression of Chronic Kidney Disease in Patients with Metabolic Acidosis.
    J Am Soc Nephrol 2024.

  4. Hollemans RA, Timmerhuis HC, Besselink MG, Bouwense SAW, et al.
    Long-term follow-up study of necrotising pancreatitis: interventions, complications and quality of life.
    Gut 2024.

  5. Bagnato F, Sati P, Hemond CC, Elliott C, et al.
    Imaging chronic active lesions in multiple sclerosis: a consensus statement.
    Brain 2024.

  1. Huwiler VV, Maissen-Abgottspon S, Stanga Z, Muehlebach S, et al.
    Selenium Supplementation in Patients with Hashimoto Thyroiditis - A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
    Thyroid 2024.

  2. Palmowski L, von Busch A, Unterberg M, Bergmann L, et al.
    Timely Cessation of Proton Pump Inhibitors in Critically Ill Patients Impacts Morbidity and Mortality: A Propensity Score-Matched Cohort Study.
    Crit Care Med 2024;52:190-199.

  3. Mok T, Nakagawa K, Park K, Ohe Y, et al.
    Nivolumab Plus Chemotherapy in Epidermal Growth Factor Receptor-Mutated Metastatic Non-Small-Cell Lung Cancer After Disease Progression on Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: Final Results of CheckMate 722.
    J Clin Oncol 2024.

  4. Bellucci M, Castellano C, Marinelli L, Garbarino L, et al.
    Patient With Rigidity and Fasciculations.
    Neurology 2024;102:e208110.

  5. Bacharier LB, Pavord ID, Maspero JF, Jackson DJ, et al.
    Blood eosinophils and FeNO are prognostic and predictive biomarkers in childhood asthma.
    J Allergy Clin Immunol 2024.


more..

Privacy Policy